Emeritas Research Group /ID# 276457 — Lansdowne Town Center, Virginia

Emeritas Research Group /ID# 276457 is a clinical research site located in Lansdowne Town Center, Virginia, United States 20176.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Emeritas Research Group /ID# 276457 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Ulcerative Colitis.

Sponsors: AbbVie.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Lansdowne Town Center

Browse all research sites in Virginia · View every site in Lansdowne Town Center

• Emeritas Research Group
• Research Site
• Emeritas Group Research
• National Sports Medicine Institute
• Theravance Biopharma Investigational Site
• Fairfax Colon & Rectal Surgery, Loudoun Office

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Emeritas Research Group /ID# 276457?

Emeritas Research Group /ID# 276457 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Emeritas Research Group /ID# 276457 conducted?

Emeritas Research Group /ID# 276457 has 1 clinical trials on record, with 1 currently active. Their work covers Ulcerative Colitis.

Is Emeritas Research Group /ID# 276457 accredited by Crixeo Clinical Trials?

Emeritas Research Group /ID# 276457 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Emeritas Research Group /ID# 276457?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.